Insider Transactions in Q1 2021 at Ab Cellera Biologics Inc. (ABCL)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 19
2021
|
Ester Falconer Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000,000
+50.0%
|
$0
$0.03 P/Share
|